1. Digoxin Injection has the effect of increasing myocardial contractility and enhancing its ability to slow down the heart rate, and is suitable for the treatment of acute and chronic cardiac insufficiency, as well as for the control of ventricular rate in patients with supraventricular tachycardia, as well as atrial flutter and atrial fibrillation with rapid ventricular rate.
2. For patients with indications for the use of the drug, the use of the drug may have a certain therapeutic effect, but due to the existence of different severity of the disease, the degree of absorption of the drug by the user, and other factors, resulting in inconsistent therapeutic effect of the user can be obtained.
3. The drug is forbidden to be used in patients with any cardiac glycoside poisoning, ventricular tachycardia, ventricular fibrillation, preexcitation syndrome with atrial fibrillation or flutter, obstructive hypertrophic cardiomyopathy (if accompanied by systolic insufficiency or atrial fibrillation can still be considered), and forbidden to be used in combination with calcium injection.
4. Common adverse reactions after use include poor appetite or nausea, vomiting, lower abdominal pain, proarrhythmia, abnormal weakness and tenderness.
Specific medication should be administered under the guidance of a specialist.